Clinical Trial Update: Co-administration of Iloprost and Eptifibatide in Septic Shock Patients [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 clinical trial evaluating co-administration of iloprost and eptifibatide in patients with septic shock.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Drugs mentioned

• EPTIFIBATIDE (EPTIFIBATIDE)
• Iloprost (iloprost)

Snippet

Sponsor: Sisse R. Ostrowski, MD PhD DMSc | Conditions: Septic Shock | Phase 2 | Status: COMPLETED